Second Line Capital LLC increased its stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 382.6% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 13,952 shares of the company's stock after buying an additional 11,061 shares during the period. Second Line Capital LLC's holdings in Procter & Gamble were worth $2,378,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Centric Wealth Management grew its stake in shares of Procter & Gamble by 172.5% in the 1st quarter. Centric Wealth Management now owns 22,975 shares of the company's stock worth $3,915,000 after buying an additional 14,543 shares during the last quarter. Titleist Asset Management LLC grew its stake in shares of Procter & Gamble by 13.1% in the 1st quarter. Titleist Asset Management LLC now owns 2,949 shares of the company's stock worth $503,000 after buying an additional 342 shares during the last quarter. Baird Financial Group Inc. grew its stake in shares of Procter & Gamble by 1.7% in the 1st quarter. Baird Financial Group Inc. now owns 1,702,004 shares of the company's stock worth $290,056,000 after buying an additional 27,710 shares during the last quarter. Pinnacle Wealth Planning Services Inc. boosted its stake in Procter & Gamble by 2.7% during the 1st quarter. Pinnacle Wealth Planning Services Inc. now owns 16,008 shares of the company's stock valued at $2,728,000 after purchasing an additional 425 shares during the last quarter. Finally, Panagora Asset Management Inc. boosted its stake in Procter & Gamble by 15.2% during the 1st quarter. Panagora Asset Management Inc. now owns 53,257 shares of the company's stock valued at $9,076,000 after purchasing an additional 7,019 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company's stock.
Procter & Gamble Trading Up 1.0%
Shares of NYSE:PG traded up $1.48 during trading hours on Monday, hitting $157.13. 5,317,408 shares of the company's stock traded hands, compared to its average volume of 6,537,981. Procter & Gamble Company has a 1 year low of $149.91 and a 1 year high of $180.43. The business has a fifty day moving average price of $156.47 and a 200-day moving average price of $162.40. The firm has a market capitalization of $368.07 billion, a P/E ratio of 24.14, a price-to-earnings-growth ratio of 4.14 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The business had revenue of $20.89 billion during the quarter, compared to analyst estimates of $20.79 billion. During the same quarter in the previous year, the business earned $1.40 earnings per share. The company's revenue for the quarter was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were given a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a dividend yield of 2.7%. The ex-dividend date was Friday, July 18th. Procter & Gamble's payout ratio is 64.98%.
Analysts Set New Price Targets
Several brokerages have commented on PG. UBS Group set a $180.00 target price on Procter & Gamble and gave the company a "buy" rating in a research note on Wednesday, July 30th. Wells Fargo & Company cut their target price on Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 30th. Barclays set a $164.00 target price on Procter & Gamble and gave the company an "equal weight" rating in a research note on Thursday, July 31st. Piper Sandler increased their target price on Procter & Gamble from $160.00 to $164.00 and gave the company a "neutral" rating in a research note on Monday, May 5th. Finally, JPMorgan Chase & Co. reiterated a "neutral" rating and set a $170.00 target price (down from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $175.12.
Get Our Latest Analysis on PG
Insider Transactions at Procter & Gamble
In related news, CEO Gary A. Coombe sold 10,194 shares of the business's stock in a transaction that occurred on Thursday, August 21st. The stock was sold at an average price of $158.16, for a total value of $1,612,283.04. Following the completion of the sale, the chief executive officer owned 34,978 shares in the company, valued at approximately $5,532,120.48. The trade was a 22.57% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Jennifer L. Davis sold 8,596 shares of the business's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $1,351,892.92. Following the completion of the sale, the chief executive officer owned 64,991 shares of the company's stock, valued at $10,221,134.57. The trade was a 11.68% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 120,181 shares of company stock valued at $18,918,012 in the last ninety days. Corporate insiders own 0.18% of the company's stock.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
